Skip to main content
All lobbying filings

UCB, Inc.

UCB, Inc. filed a Q4 report for UCB, Inc. on January 16, 2026.

Lobbying for UCB, Inc.

As filed: UCB, INC. for UCB, INC.

All filings by UCB, Inc. · Everything UCB, Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 16, 2026
Expenses
$350,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

HR 4993 - Joe Fiandra Access to Home Infusion Act of 2025 HR 4317 - PBM Reform Act of 2025

 Bills named in this filing 2
  • H.R. 4993
    Joe Fiandra Access to Home Infusion Act of 2025
  • H.R. 4317
    PBM Reform Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem